Literature DB >> 15096328

An open study of pulse pamidronate treatment in severe ankylosing spondylitis, and its effect on biochemical markers of bone turnover.

A P Cairns, S A Wright, A J Taggart, S M Coward, G D Wright.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15096328      PMCID： PMC1755338          DOI： 10.1136/ard.2004.022871

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  16 in total

Review 1.  Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis.

Authors:  J Zochling; D van der Heijde; M Dougados; J Braun
Journal:  Ann Rheum Dis       Date:  2005-08-26       Impact factor: 19.103

2.  Treatment of ankylosing spondylitis with pamidronate: an open label study.

Authors:  R Grover; S Shankar; R Aneja; V Marwaha; R Gupta; A Kumar
Journal:  Ann Rheum Dis       Date:  2006-05       Impact factor: 19.103

Review 3.  Diagnosis and management of ankylosing spondylitis.

Authors:  Claire M McVeigh; Andrew P Cairns
Journal:  BMJ       Date:  2006-09-16

Review 4.  Therapies of Early, Advanced, and Late Onset Forms of Axial Spondyloarthritis, and the Need for Treat to Target Strategies.

Authors:  Nurullah Akkoc; Gercek Can; Salvatore D'Angelo; Angela Padula; Ignazio Olivieri
Journal:  Curr Rheumatol Rep       Date:  2017-02       Impact factor: 4.592

Review 5.  Do bisphosphonates and statins have a role in spondyloarthritis management?

Authors:  Walter P Maksymowych
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

6.  [German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 8.4 Pharmaceutical therapy, 8.5 Evaluation of therapy success of pharmaceutical measures].

Authors:  U Kiltz; J Sieper; H Kellner; D Krause; M Rudwaleit; J-F Chenot; A Stallmach; S Jaresch; J Braun
Journal:  Z Rheumatol       Date:  2014-09       Impact factor: 1.372

7.  Osteoporosis in ankylosing spondylitis.

Authors:  Marina Magrey; Muhammad Asim Khan
Journal:  Curr Rheumatol Rep       Date:  2010-10       Impact factor: 4.592

8.  HLA-B27-mediated activation of TNAP phosphatase promotes pathogenic syndesmophyte formation in ankylosing spondylitis.

Authors:  Chin-Hsiu Liu; Sengupta Raj; Chun-Hsiung Chen; Kuo-Hsuan Hung; Chung-Tei Chou; Ing-Ho Chen; Jui-Teng Chien; I-Ying Lin; Shii-Yi Yang; Takashi Angata; Wen-Chan Tsai; James Cheng-Chung Wei; I-Shiang Tzeng; Shih-Chieh Hung; Kuo-I Lin
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

Review 9.  Late-onset ankylosing spondylitis and related spondylarthropathies: clinical and radiological characteristics and pharmacological treatment options.

Authors:  Eric Toussirot; Daniel Wendling
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 10.  Pamidronate treatment in rheumatology practice: a comprehensive review.

Authors:  Gleb Slobodin; Itzhak Rosner; Joy Feld; Doron Rimar; Michael Rozenbaum; Nina Boulman; Majed Odeh
Journal:  Clin Rheumatol       Date:  2009-08-19       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.